Kar Rakhee, Dolai Tuphan Kanti, Shekhawat Prakash Singh, Malhotra Pankaj, Singh Avinash, Naithani Rahul, Mandal Prakas Kumar, Ganesan Prasanth, Manivannan Prabhu, Basu Debdatta, Srivastava Alok, Das Reena, Bhattacharya Maitreyee, Mahapatra Manoranjan, Dhawan Rishi, Jain Arihant, Bhandary Chandni, Pati Hara Prasad, Chatterjee Tathagata, Tilak Vijai, Chandra Sarmila, Shetty Shrimati Dharampal, Jena Rabindra Kumar
Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
Haematology Department, NRS Medical College and Hospital, Kolkata, India.
Indian J Hematol Blood Transfus. 2021 Jan;37(1):1-9. doi: 10.1007/s12288-021-01405-0. Epub 2021 Feb 16.
The SARS-CoV-2 (COVID-19) pandemic is a worldwide public health emergency with widespread impact on health care delivery. Unforeseen challenges have been noted during administration of usual haematology care in these unusual COVID-19 times. Medical services have been overstretched and frontline health workers have borne the brunt of COVID-19 pandemic. Movement restrictions during lockdown prevented large sections of population from accessing health care, blood banks from holding blood drives, and disrupted delivery of diagnostic hematology services. The disruption in hematology care due to COVID-19 pandemic in India has been disproportionately higher compared to other subspecialities as hematology practice in India remains restricted to major cities. In this review we chronicle the challenges encountered in caring for hematology patients during the COVID-19 pandemic in India and put forth recommendations for minimizing their impact on provision of hematology care with special emphasis on hematology practice in lower and middle income countries (LMICs).
严重急性呼吸综合征冠状病毒2（SARS-CoV-2，即新冠病毒）大流行是一场全球公共卫生突发事件，对医疗服务产生了广泛影响。在这些不同寻常的新冠疫情时期，常规血液学护理的实施过程中出现了一些意想不到的挑战。医疗服务不堪重负，一线医护人员首当其冲受到新冠疫情的冲击。封锁期间的行动限制使大部分人口无法获得医疗服务，血库无法举办献血活动，诊断性血液学服务的提供也受到干扰。与其他亚专业相比，印度因新冠疫情导致的血液学护理中断情况尤为严重，因为印度的血液学实践仍局限于大城市。在本综述中，我们记录了印度在新冠疫情期间护理血液学患者时遇到的挑战，并提出建议，以尽量减少其对血液学护理提供的影响，特别强调低收入和中等收入国家（LMICs）的血液学实践。
